# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2151-2160 of 2220 results.
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Status: Recruiting
Last Changed: May 27, 2020
First Received: Dec 04, 2019
Disease(s): Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL)
Intervention(s): 8-Day Production of Car-T Cells, 12-Day Production of Car-T Cells
Locations: Medical College of Wisconsin and Froedtert Hospital, Milwaukee, Wisconsin, United States
A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Recruiting
Last Changed: Sep 11, 2020
First Received: Apr 03, 2019
Disease(s): Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin
Intervention(s): JNJ-67856633
Locations: City of Hope, Duarte, California, United States
University of Nebraska Medical Center, Omaha, Nebraska, United States
Weill Cornell Medicine, New York, New York, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
... and 32 other locations.
A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Not yet recruiting
Last Changed: Sep 18, 2020
First Received: Sep 07, 2020
Disease(s): Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
Intervention(s): JNJ-75348780
Locations: Austin Hospital, Heidelberg, Australia
Linear Clinical Research Ltd, Nedlands, Australia
Carmel Medical Center, Haifa, Israel
Hadassah Medical Center, Jerusalem, Israel
Sheba Medical Center, Ramat Gan, Israel
... and 7 other locations.
Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
Status: Completed
Last Changed: Dec 20, 2019
First Received: Nov 26, 2012
Disease(s): Leukemia Lymphocytic Chronic B-Cell
Intervention(s): CC-292, Lenalidomide
Locations: Clearview Cancer Institute Oncology Specialties, P.C, Huntsville, Alabama, United States
Horizon Oncology Center, Lafayette, Indiana, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
Mount Sinai School of Medicine, New York, New York, United States
The West Clinic, Memphis, Tennessee, United States
... and 7 other locations.
Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies
Status: Unknown status
Last Changed: Jun 22, 2016
First Received: Dec 11, 2014
Disease(s): B-Cell Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma
Intervention(s): T-cell therapy + Rituximab + IL-2
Locations: National University Hospital, Singapore, Singapore
Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL
Status: Completed
Last Changed: Jun 19, 2018
First Received: Sep 08, 2005
Disease(s): Non-Hodgkin's Lymphoma
Intervention(s): Bortezomib, CHOP, Rituximab
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Nebraska Medical Center, Omaha, Nebraska, United States
Weill Medical College of Cornell University, New York, New York, United States
Columbia University College of Physicians and Surgeons, New York, New York, United States
Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Completed
Last Changed: May 14, 2014
First Received: Nov 10, 2006
Disease(s): B-cell Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia
Intervention(s): sunitinib malate, pharmacological study, laboratory biomarker analysis
Locations: North Central Cancer Treatment Group, Rochester, Minnesota, United States
A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Status: Active, not recruiting
Last Changed: Aug 21, 2020
First Received: Mar 12, 2018
Disease(s): Leukemia, Lymphocytic, Chronic, B-Cell
Intervention(s): Ibrutinib, Venetoclax, Chlorambucil, Obinutuzumab, Ibrutinib (as Subsequent Therapy)
Locations: Norton Cancer Institute, Louisville, Kentucky, United States
John Theurer Cancer Center, Hackensack, New Jersey, United States
Novant Health, Charlotte, North Carolina, United States
ZNA Stuivenberg, Antwerpen, Belgium
Institut - Jules Bordet, Brussel, Belgium
... and 83 other locations.
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Status: Recruiting
Last Changed: Sep 10, 2020
First Received: Sep 27, 2016
Disease(s): Lymphoma, Large B-Cell, Diffuse Large B-Cell
Intervention(s): R-CHOP with doxorubicin
Locations: U.O.C. Garibaldi Nesima, Catania, CT, Italy
Divisione di Ematologia, Centro Trapianto di Cellule Staminali, San Giovanni Rotondo, Foggia, Italy
AO Riuniti Papardo Piemonte, Messina, ME, Italy
Dipartimento di Oncologia Medica ed Ematologia Istituto Clinico Humanitas, Rozzano, Milano, Italy
Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milano, MI, Italy
... and 16 other locations.
Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Completed
Last Changed: Jun 15, 2017
First Received: Jan 01, 2009
Disease(s): Leukemia, Lymphoma
Intervention(s): bevacizumab, pegfilgrastim, rituximab, cyclophosphamide, pentostatin
Locations: Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Mayo Clinic, Rochester, Minnesota, United States